Publications by authors named "Owen Martyn Bendor-Samuel"
Objective: INGR1D (INvestigating Genetic Risk for type 1 Diabetes) was a type 1 diabetes (T1D) genetic screening study established to identify participants for a primary prevention trial (POInT, Primary Oral Insulin Trial).
Methods: The majority of participants were recruited by research midwives in antenatal clinics from 18 weeks' gestation. Using the NHS Newborn Bloodspot Screening Programme (NBSP) infrastructure, participants enrolled in INGR1D had an extra sample taken from their day 5 bloodspot card sent for T1D genetic screening.
Background: Current practice in the UK is to plot premature infant anthropometric measurements on Neonatal and Infant Close Monitoring (NICM) reference charts. These charts have several known limitations. The INTERGROWTH-21st Project has recently produced international ante- and postnatal growth standards.
View Article and Find Full Text PDFArticle Synopsis
- Pituitary gigantism is a rare condition in kids that involves excessive growth and requires careful diagnosis and treatment.
- A 10½-year-old boy diagnosed with this condition had a surgery option but started with medication because of his age and personal goals related to his height.
- The case highlights the importance of teamwork among doctors and individual care plans for kids with unique medical issues.